investor.natera.comNatera, Inc. Investor Relations

Overview News EventsPresentations Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Financials Quarterly Results Annual Reports Proxy Reports IRS Forms SEC Filings Governance Executive Management Board of Directors Committee Composition Governance Documents ESG Resources Investor FAQs Information Request Form Investor Email Alerts Investor ContactsVisit Natera.com (opens in a new window) Investor Relations Overview News EventsPresentations Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Financials Quarterly Results Annual Reports Proxy Reports IRS Forms SEC Filings Governance Executive Management Board of Directors Committee Composition Governance Documents ESG Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Corporate Overview Natera™ is a global leader in cell-free DNA (cfDNA) testing with a focus on women’s health, oncology, and organ health. Our cutting-edge cfDNA technology platform combines novel molecular biology techniques with bioinformatics software and AI, allowing detection down to a single molecule in a tube of blood. We’ve leveraged this platform to develop the most accurate non-invasive prenatal test on the market (Panorama™), the first tumor-specific assay for truly individualized cancer care (Signatera™), and best-in-class rejection assessment for kidney transplantation (Prospera™), among other transformative cfDNA tests. Natera aims to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are validated by more than 200 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. Learn moreWhy Natera? Validation and Evidence We validate our tests with clinical studies and make findings publicly available. 200 + peer-reviewed publications Quality and Accuracy We meet or exceed applicable industry and regulatory standards for all our tests. CLIA-certified/ CAP-accredited laboratories Support and Transparency We provide expert support to help make our test results clear and easy to understand.70 K patient/provider support sessions annually Learn moreLatest News View all news Latest Presentation Upcoming Events View All Events Latest Quarterly Reports View All Reports Contact Us Mike Brophy Chief Financial Officer contact us by phone 510-826-2350 Send Email to [email protected] Quick Links Quarterly Results SEC Filings Investor FAQs Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the field and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Natera Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section. If you experience any issues with this process, please contact us for further assistance. By providing your email address, you are providing consent to Natera Inc. to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote EventsPresentations Unsubscribe Email Alert Sign Up Confirmation Natera Licenses IT Security Compliance Natera Notice of Data Collection for California Residents Privacy Practices Privacy Policy Terms of Use Site Map The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2024 Natera, Inc. All Rights...